[
{
"old_id":"1",
"old_nametree":"Authors and legal information",
"old_numtree":"1.0.0.0",
"old_htmlpage":"ENAS5080_1.0.0.0",
"new_id":"1",
"new_nametree":"Authors and legal information",
"new_numtree":"1.0.0.0",
"new_htmlpage":"ENAS5080_1.0.0.0"
},
{
"old_id":"2",
"old_nametree":"Definitions",
"old_numtree":"2.0.0.0",
"old_htmlpage":"ENAS5080_2.0.0.0",
"new_id":"2",
"new_nametree":"Definitions",
"new_numtree":"2.0.0.0",
"new_htmlpage":"ENAS5080_2.0.0.0"
},
{
"old_id":"3",
"old_nametree":"Diagnosis",
"old_numtree":"3.0.0.0",
"old_htmlpage":"null",
"new_id":"3",
"new_nametree":"Diagnosis",
"new_numtree":"3.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"4",
"old_nametree":"Overview",
"old_numtree":"3.1.0.0",
"old_htmlpage":"ENAS5080_3.1.0.0",
"new_id":"4",
"new_nametree":"Overview",
"new_numtree":"3.1.0.0",
"new_htmlpage":"ENAS5080_3.1.0.0"
},
{
"old_id":"5",
"old_nametree":"Cardiac troponin assays: implications",
"old_numtree":"3.2.0.0",
"old_htmlpage":"ENAS5080_3.2.0.0",
"new_id":"5",
"new_nametree":"Cardiac troponin assays: implications",
"new_numtree":"3.2.0.0",
"new_htmlpage":"ENAS5080_3.2.0.0"
},
{
"old_id":"6",
"old_nametree":"Non MI conditions with elevated troponin",
"old_numtree":"3.3.0.0",
"old_htmlpage":"ENAS5080_3.3.0.0",
"new_id":"6",
"new_nametree":"Non MI conditions with elevated troponin",
"new_numtree":"3.3.0.0",
"new_htmlpage":"ENAS5080_3.3.0.0"
},
{
"old_id":"7",
"old_nametree":"Initial assessment of suspected ACS",
"old_numtree":"3.4.0.0",
"old_htmlpage":"ENAS5080_3.4.0.0",
"new_id":"7",
"new_nametree":"Initial assessment of suspected ACS",
"new_numtree":"3.4.0.0",
"new_htmlpage":"ENAS5080_3.4.0.0"
},
{
"old_id":"8",
"old_nametree":"“Rule-in” and “rule-out” algorithms",
"old_numtree":"3.5.0.0",
"old_htmlpage":"null",
"new_id":"8",
"new_nametree":"“Rule-in” and “rule-out” algorithms",
"new_numtree":"3.5.0.0",
"new_htmlpage":"null"
},
{
"old_id":"9",
"old_nametree":"Overview",
"old_numtree":"3.5.1.0",
"old_htmlpage":"ENAS5080_3.5.1.0",
"new_id":"9",
"new_nametree":"Overview",
"new_numtree":"3.5.1.0",
"new_htmlpage":"ENAS5080_3.5.1.0"
},
{
"old_id":"10",
"old_nametree":"0h/3h rule-out algorithm",
"old_numtree":"3.5.2.0",
"old_htmlpage":"ENAS5080_3.5.2.0",
"new_id":"10",
"new_nametree":"0h/3h rule-out algorithm",
"new_numtree":"3.5.2.0",
"new_htmlpage":"ENAS5080_3.5.2.0"
},
{
"old_id":"11",
"old_nametree":"0h/1h rule-in and rule-out algorithms",
"old_numtree":"3.5.3.0",
"old_htmlpage":"ENAS5080_3.5.3.0",
"new_id":"11",
"new_nametree":"0h/1h rule-in and rule-out algorithms",
"new_numtree":"3.5.3.0",
"new_htmlpage":"ENAS5080_3.5.3.0"
},
{
"old_id":"12",
"old_nametree":"Non-invasive imaging",
"old_numtree":"3.6.0.0",
"old_htmlpage":"ENAS5080_3.6.0.0",
"new_id":"12",
"new_nametree":"Non-invasive imaging",
"new_numtree":"3.6.0.0",
"new_htmlpage":"ENAS5080_3.6.0.0"
},
{
"old_id":"13",
"old_nametree":"Differential diagnoses",
"old_numtree":"3.7.0.0",
"old_htmlpage":"null",
"new_id":"13",
"new_nametree":"Differential diagnoses",
"new_numtree":"3.7.0.0",
"new_htmlpage":"null"
},
{
"old_id":"14",
"old_nametree":"Overview",
"old_numtree":"3.7.1.0",
"old_htmlpage":"ENAS5080_3.7.1.0",
"new_id":"14",
"new_nametree":"Overview",
"new_numtree":"3.7.1.0",
"new_htmlpage":"ENAS5080_3.7.1.0"
},
{
"old_id":"15",
"old_nametree":"Differential diagnoses of ACS",
"old_numtree":"3.7.2.0",
"old_htmlpage":"ENAS5080_3.7.2.0",
"new_id":"15",
"new_nametree":"Differential diagnoses of ACS",
"new_numtree":"3.7.2.0",
"new_htmlpage":"ENAS5080_3.7.2.0"
},
{
"old_id":"16",
"old_nametree":"Risk assessment and outcomes",
"old_numtree":"4.0.0.0",
"old_htmlpage":"null",
"new_id":"16",
"new_nametree":"Risk assessment and outcomes",
"new_numtree":"4.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"17",
"old_nametree":"Introduction",
"old_numtree":"4.1.0.0",
"old_htmlpage":"ENAS5080_4.1.0.0",
"new_id":"17",
"new_nametree":"Introduction",
"new_numtree":"4.1.0.0",
"new_htmlpage":"ENAS5080_4.1.0.0"
},
{
"old_id":"18",
"old_nametree":"Unit and duration of monitoring",
"old_numtree":"4.2.0.0",
"old_htmlpage":"ENAS5080_4.2.0.0",
"new_id":"18",
"new_nametree":"Unit and duration of monitoring",
"new_numtree":"4.2.0.0",
"new_htmlpage":"ENAS5080_4.2.0.0"
},
{
"old_id":"19",
"old_nametree":"Suspected NSTE-ACS",
"old_numtree":"4.3.0.0",
"old_htmlpage":"null",
"new_id":"19",
"new_nametree":"Suspected NSTE-ACS",
"new_numtree":"4.3.0.0",
"new_htmlpage":"null"
},
{
"old_id":"20",
"old_nametree":"Diagnosis and risk stratification",
"old_numtree":"4.3.1.0",
"old_htmlpage":"ENAS5080_4.3.1.0",
"new_id":"20",
"new_nametree":"Diagnosis and risk stratification",
"new_numtree":"4.3.1.0",
"new_htmlpage":"ENAS5080_4.3.1.0"
},
{
"old_id":"21",
"old_nametree":"Imaging",
"old_numtree":"4.3.2.0",
"old_htmlpage":"ENAS5080_4.3.2.0",
"new_id":"21",
"new_nametree":"Imaging",
"new_numtree":"4.3.2.0",
"new_htmlpage":"ENAS5080_4.3.2.0"
},
{
"old_id":"22",
"old_nametree":"Monitoring",
"old_numtree":"4.3.3.0",
"old_htmlpage":"ENAS5080_4.3.3.0",
"new_id":"22",
"new_nametree":"Monitoring",
"new_numtree":"4.3.3.0",
"new_htmlpage":"ENAS5080_4.3.3.0"
},
{
"old_id":"23",
"old_nametree":"Treatment",
"old_numtree":"5.0.0.0",
"old_htmlpage":"null",
"new_id":"23",
"new_nametree":"Treatment",
"new_numtree":"5.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"24",
"old_nametree":"Pharmacological treatment of ischaemia",
"old_numtree":"5.1.0.0",
"old_htmlpage":"ENAS5080_5.1.0.0",
"new_id":"24",
"new_nametree":"Pharmacological treatment of ischaemia",
"new_numtree":"5.1.0.0",
"new_htmlpage":"ENAS5080_5.1.0.0"
},
{
"old_id":"25",
"old_nametree":"Platelet inhibition",
"old_numtree":"5.2.0.0",
"old_htmlpage":"null",
"new_id":"25",
"new_nametree":"Platelet inhibition",
"new_numtree":"5.2.0.0",
"new_htmlpage":"null"
},
{
"old_id":"26",
"old_nametree":"P2Y12 inhibitors",
"old_numtree":"5.2.1.0",
"old_htmlpage":"ENAS5080_5.2.1.0",
"new_id":"26",
"new_nametree":"P2Y12 inhibitors",
"new_numtree":"5.2.1.0",
"new_htmlpage":"ENAS5080_5.2.1.0"
},
{
"old_id":"27",
"old_nametree":"Glycoprotein IIb/IIIa inhibitors",
"old_numtree":"5.2.2.0",
"old_htmlpage":"ENAS5080_5.2.2.0",
"new_id":"27",
"new_nametree":"Glycoprotein IIb/IIIa inhibitors",
"new_numtree":"5.2.2.0",
"new_htmlpage":"ENAS5080_5.2.2.0"
},
{
"old_id":"28",
"old_nametree":"Oral antiplatelet therapy",
"old_numtree":"5.2.3.0",
"old_htmlpage":"ENAS5080_5.2.3.0",
"new_id":"28",
"new_nametree":"Oral antiplatelet therapy",
"new_numtree":"5.2.3.0",
"new_htmlpage":"ENAS5080_5.2.3.0"
},
{
"old_id":"29",
"old_nametree":"Intravenous antiplatelet therapy",
"old_numtree":"5.2.4.0",
"old_htmlpage":"ENAS5080_5.2.4.0",
"new_id":"29",
"new_nametree":"Intravenous antiplatelet therapy",
"new_numtree":"5.2.4.0",
"new_htmlpage":"ENAS5080_5.2.4.0"
},
{
"old_id":"30",
"old_nametree":"Long-term P2Y12 inhibition",
"old_numtree":"5.2.5.0",
"old_htmlpage":"ENAS5080_5.2.5.0",
"new_id":"30",
"new_nametree":"Long-term P2Y12 inhibition",
"new_numtree":"5.2.5.0",
"new_htmlpage":"ENAS5080_5.2.5.0"
},
{
"old_id":"31",
"old_nametree":"General recommendations",
"old_numtree":"5.2.6.0",
"old_htmlpage":"ENAS5080_5.2.6.0",
"new_id":"31",
"new_nametree":"General recommendations",
"new_numtree":"5.2.6.0",
"new_htmlpage":"ENAS5080_5.2.6.0"
},
{
"old_id":"32",
"old_nametree":"Anticoagulation",
"old_numtree":"5.3.0.0",
"old_htmlpage":"null",
"new_id":"32",
"new_nametree":"Anticoagulation",
"new_numtree":"5.3.0.0",
"new_htmlpage":"null"
},
{
"old_id":"33",
"old_nametree":"Dosing",
"old_numtree":"5.3.1.0",
"old_htmlpage":"ENAS5080_5.3.1.0",
"new_id":"33",
"new_nametree":"Dosing",
"new_numtree":"5.3.1.0",
"new_htmlpage":"ENAS5080_5.3.1.0"
},
{
"old_id":"34",
"old_nametree":"Treatment in NSTE-ACS",
"old_numtree":"5.3.2.0",
"old_htmlpage":"ENAS5080_5.3.2.0",
"new_id":"34",
"new_nametree":"Treatment in NSTE-ACS",
"new_numtree":"5.3.2.0",
"new_htmlpage":"ENAS5080_5.3.2.0"
},
{
"old_id":"35",
"old_nametree":"Managing oral antiplatelet agents",
"old_numtree":"5.4.0.0",
"old_htmlpage":"null",
"new_id":"35",
"new_nametree":"Managing oral antiplatelet agents",
"new_numtree":"5.4.0.0",
"new_htmlpage":"null"
},
{
"old_id":"36",
"old_nametree":"Bleeding risk reduction",
"old_numtree":"5.4.1.0",
"old_htmlpage":"ENAS5080_5.4.1.0",
"new_id":"36",
"new_nametree":"Bleeding risk reduction",
"new_numtree":"5.4.1.0",
"new_htmlpage":"ENAS5080_5.4.1.0"
},
{
"old_id":"37",
"old_nametree":"Antithrombotic strategies",
"old_numtree":"5.4.2.0",
"old_htmlpage":"ENAS5080_5.4.2.0",
"new_id":"37",
"new_nametree":"Antithrombotic strategies",
"new_numtree":"5.4.2.0",
"new_htmlpage":"ENAS5080_5.4.2.0"
},
{
"old_id":"38",
"old_nametree":"Chronic oral anticoagulation recommendations",
"old_numtree":"5.4.3.0",
"old_htmlpage":"ENAS5080_5.4.3.0",
"new_id":"38",
"new_nametree":"Chronic oral anticoagulation recommendations",
"new_numtree":"5.4.3.0",
"new_htmlpage":"ENAS5080_5.4.3.0"
},
{
"old_id":"39",
"old_nametree":"Pts. undergoing coronary stenting",
"old_numtree":"5.4.4.0",
"old_htmlpage":"ENAS5080_5.4.4.0",
"new_id":"39",
"new_nametree":"Pts. undergoing coronary stenting",
"new_numtree":"5.4.4.0",
"new_htmlpage":"ENAS5080_5.4.4.0"
},
{
"old_id":"40",
"old_nametree":"Bleeding mgmt. and blood transfusion",
"old_numtree":"5.4.5.0",
"old_htmlpage":"ENAS5080_5.4.5.0",
"new_id":"40",
"new_nametree":"Bleeding mgmt. and blood transfusion",
"new_numtree":"5.4.5.0",
"new_htmlpage":"ENAS5080_5.4.5.0"
},
{
"old_id":"41",
"old_nametree":"Invasive coronary angio. and revascularisation",
"old_numtree":"5.5.0.0",
"old_htmlpage":"null",
"new_id":"41",
"new_nametree":"Invasive coronary angio. and revascularisation",
"new_numtree":"5.5.0.0",
"new_htmlpage":"null"
},
{
"old_id":"42",
"old_nametree":"NSTE-ACS treatment strategy and timing",
"old_numtree":"5.5.1.0",
"old_htmlpage":"ENAS5080_5.5.1.0",
"new_id":"42",
"new_nametree":"NSTE-ACS treatment strategy and timing",
"new_numtree":"5.5.1.0",
"new_htmlpage":"ENAS5080_5.5.1.0"
},
{
"old_id":"43",
"old_nametree":"PCI in NSTE-ACS",
"old_numtree":"5.5.2.0",
"old_htmlpage":"ENAS5080_5.5.2.0",
"new_id":"43",
"new_nametree":"PCI in NSTE-ACS",
"new_numtree":"5.5.2.0",
"new_htmlpage":"ENAS5080_5.5.2.0"
},
{
"old_id":"44",
"old_nametree":"CABG: peri-op mgmt. of antiplatelet therapy",
"old_numtree":"5.5.3.0",
"old_htmlpage":"ENAS5080_5.5.3.0",
"new_id":"44",
"new_nametree":"CABG: peri-op mgmt. of antiplatelet therapy",
"new_numtree":"5.5.3.0",
"new_htmlpage":"ENAS5080_5.5.3.0"
},
{
"old_id":"45",
"old_nametree":"Special populations and conditions",
"old_numtree":"5.6.0.0",
"old_htmlpage":"null",
"new_id":"45",
"new_nametree":"Special populations and conditions",
"new_numtree":"5.6.0.0",
"new_htmlpage":"null"
},
{
"old_id":"46",
"old_nametree":"Elderly patients",
"old_numtree":"5.6.1.0",
"old_htmlpage":"ENAS5080_5.6.1.0",
"new_id":"46",
"new_nametree":"Elderly patients",
"new_numtree":"5.6.1.0",
"new_htmlpage":"ENAS5080_5.6.1.0"
},
{
"old_id":"47",
"old_nametree":"Diabetic patients",
"old_numtree":"5.6.2.0",
"old_htmlpage":"ENAS5080_5.6.2.0",
"new_id":"47",
"new_nametree":"Diabetic patients",
"new_numtree":"5.6.2.0",
"new_htmlpage":"ENAS5080_5.6.2.0"
},
{
"old_id":"48",
"old_nametree":"Chronic kidney disease",
"old_numtree":"5.6.3.0",
"old_htmlpage":"ENAS5080_5.6.3.0",
"new_id":"48",
"new_nametree":"Chronic kidney disease",
"new_numtree":"5.6.3.0",
"new_htmlpage":"ENAS5080_5.6.3.0"
},
{
"old_id":"49",
"old_nametree":"Acute heart failure in NSTE-ACS",
"old_numtree":"5.6.4.0",
"old_htmlpage":"ENAS5080_5.6.4.0",
"new_id":"49",
"new_nametree":"Acute heart failure in NSTE-ACS",
"new_numtree":"5.6.4.0",
"new_htmlpage":"ENAS5080_5.6.4.0"
},
{
"old_id":"50",
"old_nametree":"Heart failure following NSTE-ACS",
"old_numtree":"5.6.5.0",
"old_htmlpage":"ENAS5080_5.6.5.0",
"new_id":"50",
"new_nametree":"Heart failure following NSTE-ACS",
"new_numtree":"5.6.5.0",
"new_htmlpage":"ENAS5080_5.6.5.0"
},
{
"old_id":"51",
"old_nametree":"Atrial fibrillation",
"old_numtree":"5.6.6.0",
"old_htmlpage":"ENAS5080_5.6.6.0",
"new_id":"51",
"new_nametree":"Atrial fibrillation",
"new_numtree":"5.6.6.0",
"new_htmlpage":"ENAS5080_5.6.6.0"
},
{
"old_id":"52",
"old_nametree":"Thrombocytopenia",
"old_numtree":"5.6.7.0",
"old_htmlpage":"ENAS5080_5.6.7.0",
"new_id":"52",
"new_nametree":"Thrombocytopenia",
"new_numtree":"5.6.7.0",
"new_htmlpage":"ENAS5080_5.6.7.0"
},
{
"old_id":"53",
"old_nametree":"Long-term mgmt. post NSTE-ACS",
"old_numtree":"5.7.0.0",
"old_htmlpage":"ENAS5080_5.7.0.0",
"new_id":"53",
"new_nametree":"Long-term mgmt. post NSTE-ACS",
"new_numtree":"5.7.0.0",
"new_htmlpage":"ENAS5080_5.7.0.0"
},
{
"old_id":"54",
"old_nametree":"Summary of mgmt. strategy",
"old_numtree":"6.0.0.0",
"old_htmlpage":"null",
"new_id":"54",
"new_nametree":"Summary of mgmt. strategy",
"new_numtree":"6.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"55",
"old_nametree":"Initial evaluation and pathway",
"old_numtree":"6.1.0.0",
"old_htmlpage":"ENAS5080_6.1.0.0",
"new_id":"55",
"new_nametree":"Initial evaluation and pathway",
"new_numtree":"6.1.0.0",
"new_htmlpage":"ENAS5080_6.1.0.0"
},
{
"old_id":"56",
"old_nametree":"Diagnosis validation and risk assessment",
"old_numtree":"6.2.0.0",
"old_htmlpage":"ENAS5080_6.2.0.0",
"new_id":"56",
"new_nametree":"Diagnosis validation and risk assessment",
"new_numtree":"6.2.0.0",
"new_htmlpage":"ENAS5080_6.2.0.0"
},
{
"old_id":"57",
"old_nametree":"Antithrombotic treatment",
"old_numtree":"6.3.0.0",
"old_htmlpage":"ENAS5080_6.3.0.0",
"new_id":"57",
"new_nametree":"Antithrombotic treatment",
"new_numtree":"6.3.0.0",
"new_htmlpage":"ENAS5080_6.3.0.0"
},
{
"old_id":"58",
"old_nametree":"Invasive strategy",
"old_numtree":"6.4.0.0",
"old_htmlpage":"ENAS5080_6.4.0.0",
"new_id":"58",
"new_nametree":"Invasive strategy",
"new_numtree":"6.4.0.0",
"new_htmlpage":"ENAS5080_6.4.0.0"
},
{
"old_id":"59",
"old_nametree":"Revascularisation modalities",
"old_numtree":"6.5.0.0",
"old_htmlpage":"ENAS5080_6.5.0.0",
"new_id":"59",
"new_nametree":"Revascularisation modalities",
"new_numtree":"6.5.0.0",
"new_htmlpage":"ENAS5080_6.5.0.0"
},
{
"old_id":"60",
"old_nametree":"Hospital discharge and post-discharge mgmt.",
"old_numtree":"6.6.0.0",
"old_htmlpage":"ENAS5080_6.6.0.0",
"new_id":"60",
"new_nametree":"Hospital discharge and post-discharge mgmt.",
"new_numtree":"6.6.0.0",
"new_htmlpage":"ENAS5080_6.6.0.0"
},
{
"old_id":"61",
"old_nametree":"Abbreviations",
"old_numtree":"7.0.0.0",
"old_htmlpage":"ENAS5080_7.0.0.0",
"new_id":"61",
"new_nametree":"Abbreviations and acronyms",
"new_numtree":"7.0.0.0",
"new_htmlpage":"ENAS5080_7.0.0.0"
}
]